Serum levels of CXCL10, CCL20 and CCL22 were increased in patients with IHD.
CXCL10 and CCL20 levels were higher in diabetic than non-diabetic patients.
CCL22 levels were higher in dyslipidemic than non-dyslipidemic IHD patients.
CCL22 levels were higher in obese than non-obese IHD patients.
The SNPs rs4508917 and rs4359426 were associated with IHD.